Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19

- McQuilten, Zoe K., Venkatesh, Balasubramanian, Bangi, Ashpak K., Barina, Lauren A., Basnet, Bhupendra K., Bhally, Hasan, Bhusal, Khema R., Bogati, Umesh, Bowen, Asha C., Burke, Andrew J., Christopher, Devasahayam J., Chunilal, Sanjeev D., Jha, Vivekanand, Cochrane, B, Curnow, JL, Das, SK, Dhungana, A, Di Tanna, GL, Dotel, R, DSouza, H, Dummer, J, Dutta, S, Foo, H, Roberts, Jason, Gilbey, TL, Giles, ML, Goli, K, Gordon, A, Gyanwali, P, Haksar, D, Hudson, BJ, Jani, MK, Jevaji, PR, Jhawar, S, Morpeth, Susuan C., Jindal, A, John, MJ, John, M, John, FB, John, O, Jones, M, Joshi, RD, Kamath, P, Kang, G, Karki, AR, Totterdell, James A., Karmalkar, AM, Kaur, B, Koganti, KC, Koshy, JM, Krishnamurthy, MS, Lau, JS, Lewin, SR, Lim, L-L, Marschner, IC, Marsh, JA, McPhee, Grace M., Maze, MJ, McGree, JM, McMahon, JH, Medcalf, RL, Merriman, EG, Misal, AP, Mora, JM, Mudaliar, VK, Nguyen, V, O'Sullivan, MV, Abraham, John, Pant, S, Pant, P, Paterson, DL, Price, DJ, Rees, MA, Robinson, JO, Rogers, BA, Samuel, S, Sasadeusz, J, Sharma, D, Bam, Niraj, Sharma, PK, Shrestha, R, Shrestha, SK, Shrestha, P, Shukla, U, Shum, O, Sommerville, C, Spelman, T, Sullivan, RP, Thatavarthi, U, Bandara, Methma, Tran, HA, Trask, N, Whitehead, CL, Mahar, RK, Hammond, NE, McFadyen, JD, Snelling, TL, Davis, Joshua S., Denholm, JT, Tong, SYC

Risk of secondary progressive multiple sclerosis: a longitudinal study

- Fambiatos, Adam, Jokubaitis, Vilija, Grand'Maison, Francois, Grammond, Pierre, Sola, Patricia, Ferraro, Diana, Alroughani, Raed, Terzi, Murat, Hupperts, Raymond, Boz, Cavit, Lechner-Scott, Jeannette, Pucci, Eugenio, Horakova, Dana, Bergamaschi, Roberto, Van Pesch, V, Ozakbas, S, Granella, F, Turkoglu, R, Iuliano, G, Spitaleri, D, McCombe, P, Solaro, C, Slee, M, Kubala Havrdova, Eva Kubala, Ampapa, R, Soysal, A, Petersen, T, Sanchez-Menoyo, JL, Verheul, F, Prevost, J, Sidhom, Y, Van Wijmeersch, B, Vucic, S, Cristiano, E, Trojano, Maria, Saladino, ML, Deri, N, Barnett, M, Olascoaga, J, Moore, F, Skibina, O, Gray, O, Fragoso, Y, Yamout, B, Shaw, C, Prat, Alexandre, Singhal, B, Shuey, N, Hodgkinson, S, Altintas, A, Al-Harbi, T, Csepany, T, Taylor, B, Hughes, J, Jun, J-K, van der Walt, A, Girard, Marc, Spelman, T, Butzkueven, H, Kalincik, T, Duquette, Pierre, Lugaresi, Alessandra, Izquierdo, Guillermo

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

- Kalincik, Tomas, Kubala Havrdova, Eva, Ozakbas, Serkan, Kappos, Ludwig, Kuhle, Jens, Terzi, Murat, Lechner-Scott, Jeanette, Boz, Cavit, Grand'maison, Francois, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Horakova, Dana, Granella, Franco, Trojano, M, Bergamaschi, R, Pucci, E, Turkoglu, R, McCombe, PA, Pesch, VV, Van Wijmeersch, B, Solaro, C, Ramo-Tello, C, Izquierdo, Guillermo, Slee, M, Alroughani, R, Yamout, B, Shaygannejad, V, Spitaleri, D, Sánchez-Menoyo, JL, Ampapa, R, Hodgkinson, S, Karabudak, R, Butler, E, Prat, Alexandre, Vucic, S, Jokubaitis, V, Spelman, T, Butzkueven, H, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Onofrj, Marco, Lugaresi, Alessandra